Dr. Derya Bora Hazar, MD

Dr. Hazar practices at Attleboro Dialysis Center in Norfolk, Massachusetts.

Dr. Hazar's NPI, 1659475366, was assigned on September 12, 2006. Dr. Hazar graduated from Istanbul University, Cerrahpasa Faculty of Medicine in 1988. Dr. Hazar holds Massachusetts license 78328.

Dr. Hazar's primary practice is Attleboro Dialysis Center, at 31 Pine St, Norfolk, MA 02056 in Norfolk County. The practice phone is (508) 226-0218.

Dr. Hazar's primary practice is Attleboro Dialysis Center in Norfolk, Massachusetts. Dr. Hazar is also affiliated with Brigham and Women's Hospital. The medical group on file is Commonwealth Nephrology Associates. Dmand AI also links Dr. Hazar to 5 more hospitals, 5 medical groups, 4 group practices and clinics and 3 dialysis centers, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hazar practices, 13 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Hazar's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Hazar is board certified in nephrology by the American Board of Internal Medicine. Dmand AI has Dr. Hazar's licenses on file in 2 states: Massachusetts and Arkansas.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia and kidney cysts among the conditions Dr. Hazar treats.

CMS data shows 1,688 Medicare services from Dr. Hazar across 14 procedure codes in 2024, for 561 Medicare patients. Medicare paid $224,903 for them.

CMS counts 561 Medicare patients who saw Dr. Hazar in 2024. The largest group is 75 to 84, with 215 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 31% are also on Medicaid. Their average risk score is 4.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hazar's median patient age at 73, with 40% women.

In 2024, Dr. Hazar wrote 1,039 Medicare Part D claims for 231 patients. 77% of them were for generic drugs. CMS names the drug for 796 of them, across 23 drugs with 11 or more claims each, at $508,412 in total drug cost. In 2023, CMS named 785 claims across 24 drugs.

Dr. Hazar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Hazar in 2016. The most frequent topics are Renal Insufficiency, Chronic, Health Knowledge, Attitudes, Practice and Terminal Care. Dr. Hazar's most frequent co-authors are Stanley D. Crittenden, MD, Ravi Ishwar Thadhani, MD, MPH and Kabir Oladipo Olaniran, MD, MPH.

CMS Open Payments shows 22 general payments to Dr. Hazar from 5 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Amgen Inc. paid the most, $82.

Dmand AI lists 1 award for Dr. Hazar, most recently Boston's Top Doctors in 2023.

Dr. Hazar graduated from Istanbul University, Cerrahpasa Faculty of Medicine in 1988. Dr. Hazar is a member of ASN.

Dr. Hazar is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.